Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
7,050,136
-
Shares change
-
+20,826
-
Total reported value, excl. options
-
$58,941,000
-
Value change
-
+$163,431
-
Number of buys
-
12
-
Number of sells
-
-7
-
Price
-
$8.36
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2015
27 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2015.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,050,136 shares
of 236,833,431 outstanding shares and own 2.98% of the company stock.
Largest 10 shareholders include Aisling Capital LLC (3,608,171 shares), Consonance Capital Management LP (1,052,142 shares), Broadfin Capital, LLC (964,193 shares), FMR LLC (423,100 shares), FRANKLIN RESOURCES INC (264,099 shares), PointState Capital LP (203,158 shares), Weiss Multi-Strategy Advisers LLC (154,000 shares), J. Goldman & Co LP (121,756 shares), Alyeska Investment Group, L.P. (55,943 shares), and Telemetry Investments, L.L.C. (46,987 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.